Clinical Trial: Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis
Brief Summary: To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment.
Detailed Summary:
Sponsor: Meda Pharmaceuticals
Current Primary Outcome: Reporting of Adverse Events [ Time Frame: day 1 to day 21 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Meda Pharmaceuticals
Dates:
Date Received: April 5, 2012
Date Started: March 2012
Date Completion:
Last Updated: April 28, 2014
Last Verified: April 2014